Cargando…
The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent
We have developed a novel fluorine-18 radiotracer, dipeptide 1, radiolabeled in two steps from mesylate 3. The initial radiolabeling is achieved in a short reaction time (10 min) and purified through solid-phase extraction (SPE) with modest radiochemical yields (rcy = 10 ± 2%, n = 5) in excellent ra...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037988/ https://www.ncbi.nlm.nih.gov/pubmed/32024310 http://dx.doi.org/10.3390/molecules25030643 |
_version_ | 1783500550334054400 |
---|---|
author | Molotkov, Andrei W. Castrillon, John Santha, Sreevidya E. Harris, Paul K. Leung, David Mintz, Akiva Carberry, Patrick |
author_facet | Molotkov, Andrei W. Castrillon, John Santha, Sreevidya E. Harris, Paul K. Leung, David Mintz, Akiva Carberry, Patrick |
author_sort | Molotkov, Andrei |
collection | PubMed |
description | We have developed a novel fluorine-18 radiotracer, dipeptide 1, radiolabeled in two steps from mesylate 3. The initial radiolabeling is achieved in a short reaction time (10 min) and purified through solid-phase extraction (SPE) with modest radiochemical yields (rcy = 10 ± 2%, n = 5) in excellent radiochemical purity (rcp > 99%, n = 5). The de-protection of the tert-butyloxycarbonyl (Boc) and trityl group was achieved with mild heating under acidic conditions to provide (18)F-tagged dipeptide 1. Preliminary analysis of (18)F-dipeptide 1 was performed to confirm uptake by peptide transporters (PepTs) in human pancreatic carcinoma cell lines Panc1, BxPC3, and ASpc1, which are reported to express the peptide transporter 1 (PepT1). Furthermore, we confirmed in vivo uptake of (18)F-dipeptide tracer 1 using microPET/CT in mice harboring subcutaneous flank Panc1, BxPC3, and Aspc1 tumors. In conclusion, we have established the radiolabeling of dipeptide 1 with fluoride-18, and demonstrated its potential as an imaging agent which may have clinical applications for the diagnosis of pancreatic carcinomas. |
format | Online Article Text |
id | pubmed-7037988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70379882020-03-10 The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent Molotkov, Andrei W. Castrillon, John Santha, Sreevidya E. Harris, Paul K. Leung, David Mintz, Akiva Carberry, Patrick Molecules Article We have developed a novel fluorine-18 radiotracer, dipeptide 1, radiolabeled in two steps from mesylate 3. The initial radiolabeling is achieved in a short reaction time (10 min) and purified through solid-phase extraction (SPE) with modest radiochemical yields (rcy = 10 ± 2%, n = 5) in excellent radiochemical purity (rcp > 99%, n = 5). The de-protection of the tert-butyloxycarbonyl (Boc) and trityl group was achieved with mild heating under acidic conditions to provide (18)F-tagged dipeptide 1. Preliminary analysis of (18)F-dipeptide 1 was performed to confirm uptake by peptide transporters (PepTs) in human pancreatic carcinoma cell lines Panc1, BxPC3, and ASpc1, which are reported to express the peptide transporter 1 (PepT1). Furthermore, we confirmed in vivo uptake of (18)F-dipeptide tracer 1 using microPET/CT in mice harboring subcutaneous flank Panc1, BxPC3, and Aspc1 tumors. In conclusion, we have established the radiolabeling of dipeptide 1 with fluoride-18, and demonstrated its potential as an imaging agent which may have clinical applications for the diagnosis of pancreatic carcinomas. MDPI 2020-02-02 /pmc/articles/PMC7037988/ /pubmed/32024310 http://dx.doi.org/10.3390/molecules25030643 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Molotkov, Andrei W. Castrillon, John Santha, Sreevidya E. Harris, Paul K. Leung, David Mintz, Akiva Carberry, Patrick The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title | The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title_full | The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title_fullStr | The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title_full_unstemmed | The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title_short | The Radiolabeling of a Gly-Sar Dipeptide Derivative with Flourine-18 and Its Use as a Potential Peptide Transporter PET Imaging Agent |
title_sort | radiolabeling of a gly-sar dipeptide derivative with flourine-18 and its use as a potential peptide transporter pet imaging agent |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037988/ https://www.ncbi.nlm.nih.gov/pubmed/32024310 http://dx.doi.org/10.3390/molecules25030643 |
work_keys_str_mv | AT molotkovandrei theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT wcastrillonjohn theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT santhasreevidya theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT eharrispaul theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT kleungdavid theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT mintzakiva theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT carberrypatrick theradiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT molotkovandrei radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT wcastrillonjohn radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT santhasreevidya radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT eharrispaul radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT kleungdavid radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT mintzakiva radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent AT carberrypatrick radiolabelingofaglysardipeptidederivativewithflourine18anditsuseasapotentialpeptidetransporterpetimagingagent |